As Operating Partner with BroadOak, Mr. Poltilove leads the firm’s investments in Cell and Gene Therapy as well as the related sectors of bioproduction and cell biology. Bryan joined BroadOak after 12 years with Thermo Fisher Scientific, where he served as Vice President and General Manager. Bryan built the company’s cell and gene therapy business which he grew organically at 50%+ CAGR and through acquisitions, including Brammer Bio. Prior to Thermo Fisher, Bryan served as Director of Revenue Strategy & Operations at the Corporate Executive Board and also held several commercial strategy roles with Johnson & Johnson.
Bryan holds B.S. degrees in both Chemical Engineering and Economics from the Massachusetts Institute of Technology as well as an M.B.A. from the J.L. Kellogg School of Management at Northwestern University.
After several decades in the life sciences industry, I love the innovation in our portfolio companies.
We partner with life sciences companies to help them achieve their full potential.